# EDGAR Filing Document

**Accession Number:** 0001651717
**File Stem:** 0001651717-25-000034
**Filing Date:** 2025-9
**Character Count:** 91279
**Document Hash:** 7fa5fa5180372d1a945702e2ed2be3bd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001651717-25-000034.hdr.sgml**: 20250903

**ACCESSION NUMBER**: 0001651717-25-000034

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 58

**CONFORMED PERIOD OF REPORT**: 20250903

**FILED AS OF DATE**: 20250903

**DATE AS OF CHANGE**: 20250903

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nomad Foods Ltd
- **CENTRAL INDEX KEY:** 0001651717
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37669
- **FILM NUMBER:** 251287709

**BUSINESS ADDRESS:**
- **STREET 1:** FORGE
- **STREET 2:** 43 CHURCH STREET WEST
- **CITY:** WOKING
- **STATE:** X0
- **ZIP:** GU21 6HT
- **BUSINESS PHONE:** 00442089183200

**MAIL ADDRESS:**
- **STREET 1:** FORGE
- **STREET 2:** 43 CHURCH STREET WEST
- **CITY:** WOKING
- **STATE:** X0
- **ZIP:** GU21 6HT

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_______________________________________________

**FORM 6-K** 

_______________________________________________

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

_______________________________________________

**For the month of September 2025**

**Commission File Number: 001-37669**

_______________________________________________

**Nomad Foods Limited**

**(Translation of registrant's name in English)**

_______________________________________________

**Forge, 43 Church Street West**

**Woking, GU21 6HT**

**+ (44) 208 918 3200**

**(Address of Principal Executive Offices)**

_______________________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ⌧&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F □

**Note**: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): □

**Note**: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

------

**Investor Presentation**

Stéfan Descheemaeker, Chief Executive Officer, and Ruben Baldew, Chief Financial Officer, are scheduled to present at the Barclays Global Consumer Staples Conference scheduled for today, Wednesday, September 3, 2025, at 3:45 PM Eastern time, where they will reiterate 2025 guidance, announce a new 2026-2028 productivity program, announce new medium-term financial targets and provide an update on commercial plans. A copy of the press release and investor presentation that contains this preliminary information is furnished as Exhibit 99.1 and Exhibit 99.2 to this Report on Form 6-K.

*Forward Looking Statements: The financial information set forth in this Report reflects the Company's current estimates, is subject to the completion of its audit process, and is subject to change. The Company's 2025 results could differ materially from the guidance provided in this Report. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date of this Report. We undertake no obligation to publicly release the results of any revision or update of the forward-looking statements, except as required by the law.*

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| NOMAD FOODS LIMITED | NOMAD FOODS LIMITED |
| By: | /s/ Ruben Baldew |
| Name: | Ruben Baldew |
| Title: | Chief Financial Officer |

---

Dated: September 3, 2025

------

**<u>Exhibit Index</u>**

---

| | |
|:---|:---|
| **<u>Exhibit<br>Number</u>** | **<u>Exhibit Title</u>** |
| <u>[99.1](ex991pressrelease-septembe.htm)</u> | Press release issued by Nomad Foods Limited on September 3, 2025. |
| <u>[99.2](b2s2025finalforposting.htm)</u> | Nomad Foods Limited Barclays Presentation. |

---

## Exhibit 99.1

**Exhibit 99.1**

![nomadlogoa15.jpg](nomadlogoa15.jpg)

**Nomad Foods Announces New Financial Targets and Efficiency Program Ahead of an Investor Conference** 

*2025 guidance reiterated*

*Increased multi-year efficiency program expected to deliver €200 million in operational savings through 2028*

*New medium-term Adjusted EBITDA and Free Cash Flow growth targets established*

WOKING, England - September 3, 2025 - Nomad Foods Limited (NYSE: NOMD), today reiterated its 2025 guidance, announced plans to deliver accelerated efficiency savings from 2026 to 2028 and established new medium-term financial targets ahead of its presentation at Barclays Global Consumer Staples Conference.

***2025 Guidance Reiterated***

The Company continues to expect full year organic revenue to be flat to -2% year-on-year, full year Adjusted EBITDA of -3% to -7% year-on-year and Adjusted EPS to be in a range of €1.64 to €1.76. Furthermore, fiscal 2025 Adjusted free cash flow conversion guidance remains 90% or greater.

***Increased Efficiency Program***

The company has established an efficiency program designed to generate €200 million of operational savings over the fiscal 2026 to 2028 time frame. Savings are expected to be broad-based with a new Procurement Transformational Program (PtP) expected to be the largest contributor. Next to that the company is taking action to improve its manufacturing network utilization, reduce logistics costs and unlock overhead efficiencies. The company believes the anticipated savings will allow it to fund targeted reinvestments, mitigate inflation where needed and achieve its Adjusted EBITDA growth goals.

***New Medium-Term Targets***

Over the full 2026 to 2028 time frame the company is committing to a dependable bottom-line growth goal and healthy free-cash-flow generation. It is targeting compound annual Adjusted EBITDA growth of 1-3% over the aggregate period and expects to generate Free-Cash-Flow growth of approximately 15% from 2026-2028 versus 2023-2025. The Free-Cash-Flow improvement is expected to come from lower exceptional cash expenses, continued stringent working capital management and EBITDA growth. While not guiding to specific revenue targets, the company aims to grow organic sales in-line with the European Frozen category which, per Global Data, has historically grown sales in a low-single-digit range.

***Commercial Plan Updates***

The company plans to unveil numerous marketing and advertising initiatives during its presentation at the conference. Key highlights include a new multi-media Masterbrand campaign in the UK and Ireland that reinforces the nutrition and taste credentials of its Birds Eye brand while delivering recipe inspiration for its core hero products like Fish Fingers, Peas, Chicken Dippers and Potatoes. The company expects to extend the campaign more broadly throughout Europe in 2026.

Innovation and renovation also remain critical components of Nomad's Commercial Flywheel and the company will highlight a number of new products including the upcoming *get Real* protein meal bowl launch, the recent McDonald's Veggie Nugget restaurant launch in the Nordic region, and a wide range of chicken launches including the introduction of the new *Chicken Station* sub-brand in Italy, new Chicken Fries behind the *Chicken Shop* sub-brand in the UK, and new products that expand its *Chicken Stripes* range in Germany.

***Management Comments***

Stéfan Descheemaeker, Nomad Foods' Chief Executive Officer, stated, "While we have faced challenges in 2025, we are proud to have successfully stabilized market share, demonstrating that our Commercial Flywheel is working. We have numerous initiatives underway to drive profitable sales growth for the remainder of 2025 and into 2026. I'm excited about the new and impactful Masterbrand campaign that we will be launching in the Fall. This campaign will be accompanied by a wide range of innovation and renovation initiatives to support our brands and further advance the number of core Must Win Battles where we achieve measured superiority among consumers."

Ruben Baldew, Nomad Food's Chief Financial Officer, added, "Our sales and marketing teams are developing strong commercial plans and we are taking additional steps to increase our ability to deliver consistent and predictable bottom line growth. Today we are unveiling a new efficiency program that will help us mitigate inflation, fund investments and drive Adjusted EBITDA growth. We are also aiming to reduce exceptional expenses and thereby improve Free Cash Flow to enhance our ability to pursue strategic actions or

------

**Exhibit 99.1**

return cash to shareholders. And, as reflected by our new medium term EBITDA growth target, we are intent to set realistic goals that investors can depend on us achieving."

***Presentation webcast***

The company's presentation is scheduled for 3:45 pm EST on Wednesday, September 3<sup>rd</sup>. A webcast of the presentation will be available at www.nomadfoods.com under Investor Relations.

***Enquiries***

**Investor Relations Contact**

Jason English

investorrelations@nomadfoods.com

**Media Contact**<br>Oliver Thomas, Head of Corporate Affairs<br>Oliver.Thomas@nomadfoods.com

***About Nomad Foods***

Nomad Foods (NYSE: NOMD) is Europe's leading frozen food company. The Company's portfolio of iconic brands, which includes *Birds Eye*, *Findus*, *iglo*, *Ledo* and *Frikom*, has been a part of consumers' meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

**Non-IFRS Financial Information**

Nomad Foods is presenting Adjusted and Organic forecast financial information, which is considered non-IFRS financial information, for the fiscal year 2025.

Adjusted financial information reflects the historical reported financial statements of Nomad Foods, adjusted primarily for, when they occur, share based payment expenses and related employer payroll taxes, non-operating M&A related costs, acquisition purchase price adjustments, exceptional items and foreign currency translation charges/gains.

Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance.

Adjusted EPS is defined as basic earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

Organic revenue growth/(decline) is an adjusted measurement of our operating results. Organic revenue growth/(decline) reflects reported revenue adjusted for currency translation and non-comparable trading items such as expansion, acquisitions, disposals, closures, trading day impacts or any other event that artificially impacts the comparability of our results period over period.

Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.

Adjusted Free Cash Flow – Adjusted free cash flow is the amount of cash generated from operating activities before cash flows related to exceptional items (as described above), non-operating M&A related costs and working capital movements on employer taxes associated with share based payment awards, but after capital expenditure (on property, plant and equipment and intangible assets), net

------

interest paid, proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and payments of lease liabilities. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives.

Cash flow conversion is Adjusted Free Cash Flow as percentage of Adjusted Profit for the period.

Adjusted and Organic non-IFRS financial information should be read in conjunction with the historical financial statements of the Company previously filed with the SEC.

Nomad Foods believe its non-IFRS financial measures provide an important additional measure with which to monitor and evaluate the Company's ongoing financial results, as well as to reflect its acquisitions. Nomad Foods' calculation of these financial measures may be different from the calculations used by other companies and comparability may therefore be limited. The Adjusted and Organic financial information presented herein is based upon certain assumptions that Nomad Foods believes to be reasonable and is presented for informational purposes only and is not necessarily indicative of any anticipated financial position or future results of operations that the Company will experience. You should not consider the Company's non-IFRS financial measures an alternative or substitute for the Company's reported results and are cautioned not to place undue reliance on these results and information as they may not be representative of our actual or future results as a Company.

The Company is unable to reconcile, without unreasonable efforts, Organic Growth, Adjusted EBITDA, Adjusted Free Cash Flow conversion and Adjusted EPS guidance to the most directly comparable IFRS measure.

**<u>Forward-Looking Statements and Disclaimers</u>**

Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including the Company's expectations regarding (i) its future operating and financial performance, including its 2025 guidance with respect to organic revenue growth, Adjusted EBITDA growth, adjusted free cash flow conversion, Adjusted EPS, and Adjusted EPS growth; (ii) its increased efficiency program, (iii) its growth initiatives, including with respect to its innovation and renovation initiatives, (iv) its medium-term targets, including with respect to Adjusted EBITDA growth, free cash flow growth and organic sales growth; (v) its bottom-line growth and cash generation; (vi) its ability to drive profitable sales growth in 2025 and into 2026, and (vii) its ability to reduce expenses and enhance its ability to pursue strategic actions or return cash to shareholders.

These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in Ukraine and climate-related factors beyond the Company's control; (ii) the Company's ability to successfully mitigate inflationary changes in the market; (iii) the Company's ability to successfully identify suitable acquisition targets and adequately evaluate the potential performance of such acquisition targets; (iv) the Company's ability to successfully implement its strategies (including its M&A strategy) and strategic initiatives and to recognize the anticipated benefits of such strategic initiatives; (v) innovations introduced to the markets and the Company's ability to accurately forecast the brands' performance; (vi) the Company's ability to effectively compete in its markets; (vii) changes in consumer preferences, such as meat substitutes, and the Company's failure to anticipate and respond to such changes or to successfully develop and renovate products; (viii) the effects of reputational damage from unsafe or poor quality food products; (ix) the risk that securities markets will react negatively to actions by the Company; (x) the adequacy of the Company's cash resources to achieve its anticipated growth agenda; (xi) increases in operating costs, including labor costs, and the Company's ability to manage its cost structure; (xii) fluctuations in the availability of food ingredients and packaging materials that the Company uses in its products; (xiii) the Company's ability to protect its brand names and trademarks; (xiv) the Company's ability to prevent, or remediate, any future cybersecurity incidents; (xv) loss of the Company's financial arrangements with respect to receivables factoring; (xvi) the loss of any of the Company's major customers or a decrease in demand for its products; (xvii) economic conditions that may affect the Company's future performance including exchange rate fluctuations; (xviii) the Company's ability to successfully interpret and respond to key industry trends and to realize the expected benefits of its responsive actions; (xix) the Company's failure to comply with, and liabilities related to, environmental, health and safety laws and regulations; (xx) changes in applicable laws or regulations; (xxi) the Company's ability to remediate any material weaknesses in its internal control over financial reporting; (xxii) the impact of weather conditions, natural disasters, and other factors beyond the Company's control, and (xxiii) the other risks and uncertainties disclosed in the Company's public filings and any other public disclosures by the Company. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company does not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

**<u>No Offer or Solicitation</u>**

------

This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law.

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

## Exhibit 99.2

![](b2s2025finalforposting001.jpg)

September 2025 Barclays Global Staples Conference

------

![](b2s2025finalforposting002.jpg)

This Presentation has been prepared and issued by Nomad Foods Limited (the "Company"). This Presentation has been provided solely for information and background. The information in this Presentation is provided as at the date of the Presentation (unless stated otherwise). This Presentation does not constitute or form part of, and should not be construed as: (i) an offer, solicitation or invitation to subscribe for, sell or issue, underwrite or otherwise acquire any securities or financial instruments, nor shall it, or the fact of its communication, form the basis of, or be relied upon in connection with, or act as any inducement to enter into any contract or commitment whatsoever with respect to such securities or financial instruments, or (ii) any form of financial opinion, recommendation or investment advice with respect to any securities or financial instruments. Certain statements and matters discussed in this Presentation may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "aim", "anticipate", "believe", "continue", "estimate", "expect", "intend", "may", "should", "strategy", "will" and words of similar meaning, including all matters that are not historical facts. This Presentation includes forward-looking statements about the Company's expectations regarding: (i) its future operating and financial performance, including its expectations regarding sales trends, margins, capital expenditures, market share performance, and organic sales growth, (ii) its 2025 guidance, including with respect to revenue, revenue growth, organic revenue, organic revenue growth, Adjusted free cash flow conversion, Adjusted EBITDA growth, gross margin, Adjusted EPS, and Adjusted EPS growth, (iii) its 2026-2028 targets and enablers, including with respect to Adjusted EBITDA, Free Cash, and Cost of Goods Sold, , (iv) its ability to grow free cash flow and create sustainable, long-term growth, (v) its continued investment in A&P and A&P spend, (vi) 2026-2028 non-recurring expenditures, (vii) its innovation and renovation, including the expected timing, acceleration and success of new and improved products, and the impact of innovation on sales rates in 2025, (viii) customer demographics and demand, (ix) its cost and overhead savings targets, (x) growth in the frozen food category, including industry trends, long-term growth opportunities and the Company's advantages, (xi) the drivers of its organic growth, including its capital allocation strategy, (xii) its ability to offset higher costs with incremental pricing and any potential impacts to gross margin, and (xiii) its ability to maximize shareholder returns, including through future dividends and share repurchases and any potential M&A activity. The forward-looking statements in this Presentation speak only as of the date hereof and are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in Ukraine; (ii) the Company's ability to successfully mitigate inflationary changes in the market, (iii) disruptions or inefficiencies in the Company's operations or supply chain, including as a result of the conflict in Ukraine or trade conflicts; (iv) the Company's ability to successfully implement its strategies (including its M&A and A&P strategies) or strategic initiatives and recognize the anticipated benefits of such strategic initiatives; (v) innovations introduced to the markets and the Company's ability to accurately forecast the brands' performance; (vi) the Company's ability to effectively compete in its markets, including the ability to capture a greater share of the frozen food market; (vii) changes in consumer preferences, such as meat substitutes, and the Company's failure to anticipate and respond to such changes or to successfully develop and renovate products; (viii) the impact of weather conditions, natural disasters, and other factors beyond the Company's control on the Company's business, suppliers, co-manufacturers, distributors, transportation or logistics providers, customers, consumers and employees, and the Company's ability to maintain the health and safety of its workforce; (ix) the effects of reputational damage from unsafe or poor quality food products; (x) increases in operating costs, including labor costs, and the Company's ability to manage its cost structure; (xi) fluctuations in the availability of food ingredients and packaging materials that the Company uses in its products; (xii) the Company's ability to protect its brand names and trademarks; (xiii) the Company's ability to prevent, or remediate, any future cybersecurity incidents; (xiv) the loss of any of the Company's major customers or a decrease in demand for its products; (xv) economic conditions that may affect the Company's future performance including exchange rate fluctuations and trade conflicts; (xvi) the Company's ability to remediate any material weaknesses in its internal control over financial reporting; and (xvii) the other risks and uncertainties disclosed in the Company's public filings and any other public disclosures by the Company. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Other than in accordance with its legal or regulatory obligations, the Company is not under any obligation and the Company and its affiliates expressly disclaim any intention, obligation or undertaking to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This Presentation shall not, under any circumstances, create any implication that there has been no change in the business or affairs of the Company since the date of this Presentation or that the information contained herein is correct as at any time subsequent to its date. No statement in this Presentation is intended as a profit forecast or estimate. Unless otherwise indicated, market and competitive position data in this Presentation has been published by Nielsen or Euromonitor. Given this data has been obtained from industry publications and surveys or studies conducted by third-party sources, there are limitations with respect to the availability, accuracy, completeness and comparability of such data. The Company has not independently verified such data, can provide no assurance of its accuracy or completeness and is not under any obligation to update, complete, revise or keep current the information contained in this Presentation. Certain statements in this document regarding the market and competitive position data are based on the internal analyses of the Company, which involves certain assumptions and estimates. These internal analyses have not been verified by any independent sources and there can be no assurance that the assumptions or estimates are accurate. This Presentation includes certain additional key performance indicators which are considered non-IFRS financial measures including, but not limited to, organic revenue growth, Adjusted EBITDA, Adjusted EPS, Adjusted EPS growth, Adjusted EBITDA growth, Adjusted operating expenses, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion, and Free Cash. Nomad Foods believes these non-IFRS financial measures provide an important alternative measure with which to monitor and evaluate the Company's ongoing financial results, as well as to reflect its acquisitions. Nomad Foods' calculation of these financial measures may be different from the calculations used by other companies and comparability may therefore be limited. You should not consider the Company's non-IFRS financial measures an alternative or substitute for the Company's reported results. For a reconciliation of these non- IFRS financial measures to the most directly comparable IFRS measures, refer to the Appendix to this Presentation. The Company is unable to reconcile, without unreasonable efforts, Adjusted EBITDA, Organic Revenue, Adjusted EPS, Free Cash and Adjusted Free Cash Flow Conversion guidance to the most directly comparable IFRS measures. Disclaimer 2

------

![](b2s2025finalforposting003.jpg)

Our Brands Lead #1 BRAND EQUITY IN 13/15 MARKETS #1 PREFERENCE IN 12/15 MARKETS #1 BRAND AWARENESS IN 12/15 MARKETS 46% Weighted average value market share in our top 25 must-win battles (37% volume share) 2.6x Higher market share than all other branded competitors combined in our top 25 must-win battles. Iconic Brands with Leading Market Share & Equity Source: NielsenIQ and Circana, 12-wks ending P10 2024 3

------

![](b2s2025finalforposting004.jpg)

Adjusted EPS\* 8% CAGR Revenues 5% CAGR Adjusted EBITDA\* 6% CAGR A Long Track Record of Growth €0.84 €1.78 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025\*\* €325 million 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025\*\* €1.9 billion €3.1 billion 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025\*\* €537 million \*Represents a non-IFRS measure. Please see Appendix for a reconciliation of these non-IFRS measures to their directly comparable measures \*\* Based on the mid-point of current FY25 guidance 4

------

![](b2s2025finalforposting005.jpg)

A Challenging 2025 Adjusted Gross Margin\* 2021 2022 2023 2024 1H25 -1.4% -1.2% 0.5% 1.4% -1.0% Organic Sales Growth\* Organic YoY Gross MarginPriceVolume 1Q24 2Q24 3Q24 4Q24 1Q25 Inventory Destock 2Q25 Second Half\*\* Source: Company fillings. \*Represents a non-IFRS measure. Please see Appendix for a reconciliation of these non-IFRS measures to their directly comparable measures \*\* Reflects implied second half organic sales growth range based on full year guidance and first half results. 5 Weather Disruption

------

![](b2s2025finalforposting006.jpg)

Total Europe YoY Value Sales Growth 10-yr CAGR: Frozen ex ice cream & desserts 3.4% Total Food 3.0% Frozen Food Our Category Has a Long Record of Growth 2015 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 1.5% 0.4% 2.3% 2.3% 7.3% 4.2% 2.7% 3.0% 1.2% 5.6% 5.4% Source: Global Data. 6

------

![](b2s2025finalforposting007.jpg)

Frozen is an Advantaged Category in Europe, Backed by Secular Trends Convenience Value 93% of European consumers have changed the way they shop to manage expenditures Meals made from frozen cost €2-3 less compared to chilled equivalents Sustainability Frozen Food reduces waste which is good for the planet and saves consumers and retailers money 43% of shoppers prefer to buy frozen food as it reduces waste Source: Kantar; Institute of Grocery Distribution; Manchester Food Research Centre; Bounce Research in UK/IT/DE 7 Families spend an average of 25 minutes preparing their main meal 68% of consumers agree that frozen food provides some short-cuts compared to chilled/fresh food, thereby saving them time

------

![](b2s2025finalforposting008.jpg)

18.2 15.0 11.9 11.0 10.9 9.9 9.4 9.4 8.2 8.1 7.8 7.3 7.2 5.3 3.2 3.0 3.0 Frozen Food Volume (kg.) Per Capita Consumption A Long Runway of Growth Source: Global Data & NIQ – Total Frozen Food excluding Ice cream; https://worldometers.info 8

------

![](b2s2025finalforposting009.jpg)

Nomad Foods Revenue Split Others 16% Meals 17% Vegetables 25% Poultry 9% Fish & Seafood 33% Protein 42% Our Portfolio Skews Towards Nutritious Food Nutrition 2/3rd of our revenue Frozen skews towards protein and vegetables which account for Source: Nomad Foods 1H 2024 Net Sales 9

------

![](b2s2025finalforposting010.jpg)

New Masterbrand Advertising Campaign - TV 10

------

![](b2s2025finalforposting011.jpg)

Implement and Launch Develop Design Discover and Define Frame the Challenge Innovation as a percent of revenue 2024 2025E2023 4.2% Near 5% Ramping Innovation Product Innovation Wheel Note: Innovation defined as revenue generated by new products introduced within the past two years 11

------

![](b2s2025finalforposting012.jpg)

Innovating in Meals

------

![](b2s2025finalforposting013.jpg)

Scaling our Poultry Portfolio Loaded Burgers Chicken WingsFillet Burgers Tenders & Fries 13

------

![](b2s2025finalforposting014.jpg)

Source: NielsenIQ & Circana 14 Prepared Poultry Share (roling 12-wk periods) 8,7% 18,2% 2024 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P1 P2 P3 P4 P5 P6 2025

------

![](b2s2025finalforposting015.jpg)

Driving Growth in Foodservice LAUNCHED JUNE 2025 McDonalds Veggie Nuggets (chicken-free) A healthy meal choice vegetarian and vegan alternative to the classic McNuggets, for main meals and happy meal

------

![](b2s2025finalforposting016.jpg)

Market Share has Stabilized 0% 2024 2025 R12 wk Value Share R12 wk Volume Share P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P1 P2 P3 P4 P5 P6 P7 Source: NielsenIQ & Circana 16

------

![](b2s2025finalforposting017.jpg)

Recent Category Volatility Frozen Category Growth in Select European Countries\*; rolling 4 wk period P1 P2 P3 P4 P5 P6 P7 P8 Value Volume Weather Disruption 0% Source: NielsenIQ & Circana \*Countries include Belgium, France, Ireland, Netherlands, Norway, Portugal, Spain, Sweden & the UK; selection based on availability of P8 data. 17

------

![](b2s2025finalforposting018.jpg)

€1.64- €1.76 Adjusted Free Cash Flow Conversion\*\* Adjusted EPS\*\* 2025 Guidance -3% to -7% growth 0% to -2% YoY Organic Revenue\*\* Adjusted EBITDA\*\* 90%+ $1.90-$2.04\* \*2025 Adjusted EPS guidance range converted to USD, the currency in which Nomad Foods shares trade, for illustrative purposes and based on USD/EUR FX rate of 1.16 as of August 27, 2025. \*\*Represents a non-IFRS measure. Please see Appendix for a description of these non-IFRS measures. 18

------

![](b2s2025finalforposting019.jpg)

Our Targets Adjusted EBITDA\* +1% to +3% growth Free Cash Flow\* +15% (2026-28 vs. 2023-25) Our 2026-2028 Output Targets and Enablers Our Enablers €200m productivity program with expected savings in: • Procurement • Conversion Costs • Logistics • Overheads Leveraging healthy category tailwinds • Secular tailwinds should fuel industry growth • Investments to hold or grow share over time Funding reinvestment in product & brands • Quality & Renovation • Innovation • A&P • Merchandising \*Represents a non-IFRS measure. Please see Appendix for a reconciliation of these non-IFRS measures to their directly comparable measures 19

------

![](b2s2025finalforposting020.jpg)

\*Based on the mid-point of current FY25 guidance Accelerating COGS Efficiency Savings as % of COGS Cumulative COGS Savings €m\* 2023-25 €145-€150m 2026-28 Approximately €180m 2023-25 2026-28 LogisticsConversion CostsProcurement 20

------

![](b2s2025finalforposting021.jpg)

New Procurement Transformation Program 2x 2023-2025 2026-2028 Product specification Benchmarking Strategic purchasing Insource & Transform Supplier engagement Customs Inbound logistics €95-€100m procurement savings target 21

------

![](b2s2025finalforposting022.jpg)

Ambitious reduction in number of depots -22% 95 €15-€20m logistics savings target SC: Continuous Logistics Savings 2024 2025 2026 2027 2028 Value Creation Pillars 84 79 76 74 22

------

![](b2s2025finalforposting023.jpg)

SC: Improving Network Utilization Nomad Volume Co-packers 22% Inhouse 78% Non-Utilized CapacityUtilized Capacity Cost Optimisation and Volume Insourcing Network Study Average capacity utilization of 66%, ranging from 25% to 88% by plant. Production Volume Capacity by Plant 23 €60-€70m conversion cost savings target

------

![](b2s2025finalforposting024.jpg)

€20-€35m overhead savings target Delivering Overhead Efficiencies High Range Low Range 2026 2027 2028 2026-2028 Overhead Savings South Eastern EuropeBase Overhead Overhead Evolution 2018-2025\*, €m 2018 2019 2020 2021 2022 2023 2024 2025\* Lower bonus +€20m savings offset inflation +8% CAGR +5% CAGR 24 \*Based on the mid-point of current FY25 guidance

------

![](b2s2025finalforposting025.jpg)

\*Based on the mid-point of current FY25 guidance Reinvesting Efficiently A&P Spend (€, m)\* 2022 2023 2024 2025E Maximizing Efficiency & ROI Drive Productivity in non-consumer-facing marketing: • Procurement Transformation Project (new marketing specific procurement role filled in 2Q25) • Leveraging scale with master-brand campaign Making working spend work harder: • More centralized media buying with global agency partner continues to unlock savings • Marketing Mix Modelling is driving improved media ROI 25

------

![](b2s2025finalforposting026.jpg)

Nearly Halving our Exceptional Cash Expenditures 2023 2024 2025\* 68 68 76 2026 2027 2028 40 50 40 20 35 average 30 30 Exceptional Expenditures 2023-2025 (€, m) Exceptional Expenditures 2026-2028 (€, m) HighLow 71 average \*Based on the mid-point of current FY25 guidance 26

------

![](b2s2025finalforposting027.jpg)

\*Based on the mid-point of current FY25 guidance Overall Plan Expected to Generate Approximately 15% Free Cash Flow Growth 1-3% CAGR EBITDA over 3-year period: • Leverage category secular tailwinds • Drive competitiveness through €200m productivity program • Fund reinvestment Continue to drive disciplined Capex and Working Capital management • Benchmarking • Forecasting optimization • Network reduction and simplification Halving our exceptional expenditures • ROI focus • Smaller and slower transformation program focusing on process improvement 27 2026-20282023-2025\*

------

![](b2s2025finalforposting028.jpg)

Thank you.

------

![](b2s2025finalforposting029.jpg)

Questions?

------

![](b2s2025finalforposting030.jpg)

Appendix 30

------

![](b2s2025finalforposting031.jpg)

The following tables have been included to allow users to reconcile Non-IFRS financial measures as well as Adjusted financial information included within this presentation to reported IFRS financial measures. 1. Definitions of Non-IFRS financial measures referred to in this presentation. 2. Reconciliation of Non-IFRS financial measures. Contents 31

------

![](b2s2025finalforposting032.jpg)

Non-IFRS financial measures should not be considered as substitutes for, or superior to, measures of financial performance prepared in accordance with IFRS. They are limited in value because they exclude charges that have a material effect on the Company's reported results and, therefore, should not be relied upon as the sole financial measures to evaluate the Company's financial results. The non-IFRS financial measures are meant to supplement, and to be viewed in conjunction with, IFRS financial measures. Investors are encouraged to review the reconciliation of these non-IFRS financial measures to their most directly comparable IFRS financial measures as provided in the tables accompanying this document. Adjusted EBITDA – EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items to the extent included in our financial statements such as material restructuring charges, material goodwill and intangible asset impairment charges, other material unusual or non-recurring items, as well as additional items that management deems to be exceptional and appropriate for adjustment. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Adjusted Gross Profit and adjusted gross margin exclude acquisition purchase price adjustments and accelerated depreciation associated with restructuring programs, both within cost of goods sold. Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, net financing income/(cost) on amendment of terms of debt, interest cost on tax relating to legacy tax audits, foreign exchange translation gains/(losses), foreign exchange gains/(losses) on derivatives, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Adjusted EPS - Adjusted EPS is defined as diluted earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, net financing income/(cost) on amendment of terms of debt, interest cost on tax relating to legacy tax audits, foreign exchange translation gains/(losses), foreign exchange gains/(losses) on derivatives, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Adjusted Financial Information – Adjusted financial information presented in this presentation reflects the historical reported financial statements of Nomad Foods, adjusted for share based payment charges including employer payroll taxes, exceptional items (as described above) and non-cash foreign currency translation charges/gain. Organic Revenue Growth/(Decline) – Organic revenue growth/(decline) is an adjusted measurement of our operating results. This comparison of current and prior period performance takes into consideration only those activities that were in effect during both time periods. Organic revenue reflects reported revenue adjusted for currency translation and non-comparable trading items such as expansion, acquisitions, disposals, closures, trading day impacts or any other event that artificially impact the comparability of our results. Free Cash Flow – Free cash flow is the amount of cash generated from operating activities less cash flows related to (i) capital expenditure (on property, plant and equipment and intangible assets), (ii) net interest paid, (iii) proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and (iv) payments of lease liabilities. Adjusted Free Cash Flow – Adjusted free cash flow is Free cash flow (as described above) plus cash flows (i) related to exceptional items (as described above), (ii) non-operating M&A related costs and (iii) working capital movements on employer taxes associated with share based payment awards. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives. 1. Definitions of Non-IFRS financial measures referred to in this presentation 32

------

![](b2s2025finalforposting033.jpg)

33 2. Reconciliation of Non-IFRS Financial Measures (continued) As adjusted for the six months ended June 30, 2025 Adjustments As reported for the six months ended June 30, 2025 € in millions, except per share data 1,507.0—1,507.0Revenue (1,087.7)(a)1.4(1,089.1)Cost of sales 419.31.4417.9Gross profit (218.8)(b)5.8(224.6)Other operating expenses —(c)32.0(32.0)Exceptional items 200.539.2161.3Operating profit 2.7(7.8)10.5Finance income (61.5)—(61.5)Finance costs (58.8)(d)(7.8)(51.0)Net financing costs 141.731.4110.3Profit before tax (27.6)(e)(7.1)(20.5)Taxation 114.124.389.8Profit for the period 153.5153.5Weighted average shares outstanding in millions - basic 0.740.59Basic earnings per share 153.7153.7Weighted average shares outstanding in millions - diluted 0.740.58Diluted earnings per share a. Represents elimination of €1.4 million of incremental depreciation related to assets impacted by the planned closure of a factory in Sweden as part of the Company's multi-year supply chain network optimization program. b. Represents share based payment charge including employer payroll taxes of €5.3 million and non-operating M&A transaction costs of €0.5 million. c. Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) six months ended June 30, 2025' on the next slide for a detailed list of exceptional items. d. Represents elimination of €7.8 million of foreign exchange translation gains. e. Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. Adjusted Statement of Profit or Loss (unaudited) Six Months Ended June 30, 2025

------

![](b2s2025finalforposting034.jpg)

34 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (unaudited) Six months ended June 30, 2025 For the six months ended June 30, 2025€ in millions 89.8Profit for the period 20.5Taxation 51.0Net financing costs 50.3Depreciation and amortization Exceptional items: (a)21.2Business Transformation Program (b)7.8Organizational Streamlining Program (c)1.9Supply chain network optimization (d)1.1Settlement of legacy matters Other Adjustments: (e)5.8Other add-backs 249.4Adjusted EBITDA (f) a. Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees. b. Expenses associated with the enterprise-wide restructuring program relating to non-factory operations. Expenses in the period consist of restructuring and severance costs. c. Expenses associated with the supply chain network optimization program which aims to enhance operational efficiency. Expenses in the period consist primarily of severance costs. d. Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. e. Represents the elimination of share based payment charge including employer payroll taxes of €5.3 million and elimination of non-operating M&A related costs of €0.5 million. f. Adjusted EBITDA margin of 16.8% for the six months ended June 30, 2025 is calculated by dividing Adjusted EBITDA by Revenue of €1,507.0 million.

------

![](b2s2025finalforposting035.jpg)

35 2. Reconciliation of Non-IFRS Financial Measures As adjusted for the twelve months ended December 31, 2024 Adjustments As reported for the twelve months ended December 31, 2024 € in millions, except per share data 3,099.8—3,099.8Revenue (2,182.0)—(2,182.0)Cost of sales 917.8—917.8Gross profit (449.6)(a)11.7(461.3)Other operating expenses —(b)69.5(69.5)Exceptional items 468.281.2387.0Operating profit 10.0(20.1)30.1Finance income (118.2)21.0(139.2)Finance costs (108.2)(c)0.9(109.1)Net financing costs 360.082.1277.9Profit before tax (71.2)(d)(20.4)(50.8)Taxation 288.861.7227.1Profit for the period 161.5161.5Weighted average shares outstanding in millions - basic 1.791.41Basic earnings per share in € 162.2162.2Weighted average shares outstanding in millions - diluted 1.781.40Diluted earnings per share in € a. Share based payment charge including employer payroll taxes of €10.4 million and non-operating M&A related costs of €1.3 million. b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (audited) twelve months ended December 31, 2024' on the next slide for a detailed list of exceptional items. c. Elimination of €14.4 million of net gains on repricing of debt, a €5.7 million gain from the reversal of an impairment loss on a short-term investment, €20.6 million of foreign exchange translation losses and €0.4 million of losses on derivatives. d. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. Adjusted Statement of Profit or Loss (unaudited) Twelve Months Ended December 31, 2024

------

![](b2s2025finalforposting036.jpg)

36 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2024 For the twelve months ended December 31, 2024 € in millions 227.1Profit for the period 50.8Taxation 109.1Net financing costs 96.9Depreciation and amortization Exceptional items: (a)68.0Business Transformation Program (b)1.5Settlement of legacy matters Other Adjustments: (c)11.7Other add-backs 565.1Adjusted EBITDA (d) a. Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees. b. Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. c. Represents the elimination of share based payment charge including employer payroll taxes of €10.4 million and elimination of non-operating M&A related costs of €1.3 million. d. Adjusted EBITDA margin of 18.2% for the twelve months ended December 31, 2024 is calculated by dividing Adjusted EBITDA by Revenue of €3,099.8 million.

------

![](b2s2025finalforposting037.jpg)

As adjusted for the twelve months ended December 31, 2023 Adjustments As reported for the twelve months ended December 31, 2023 € in millions, except per share data 3,044.5—3,044.5Revenue (2,185.8)—(2,185.8)Cost of sales 858.7—858.7Gross profit (418.7)(a)27.1(445.8)Other operating expenses —(b)72.5(72.5)Exceptional items 440.099.6340.4Operating profit 5.8(17.0)22.8Finance income (102.1)7.5(109.6)Finance costs (96.3)(c)(9.5)(86.8)Net financing costs 343.790.1253.6Profit before tax (68.9)(d)(8.0)(60.9)Taxation 274.882.1192.7Profit for the period 170.6170.6Weighted average shares outstanding in millions - basic 1.611.13Basic earnings per share 171.2171.2Weighted average shares outstanding in millions - diluted 1.611.13Diluted earnings per share a. Share based payment charge including employer payroll taxes of €26.1 million and non-operating M&A related costs of €1.0 million. b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (audited) twelve months ended December 31, 2023' for a detailed list of exceptional items. c. Elimination of €16.7 million of net gains on repricing of debt, €3.5 million of interest cost on tax relating to legacy tax audits, €3.0 million of foreign exchange translation losses, €1.0 million of losses on derivatives and a €0.3 million gain from the reversal of an impairment loss on a short-term investment. d. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months Ended December 31, 2023 37

------

![](b2s2025finalforposting038.jpg)

As reported for the twelve months ended December 31, 2023 € in millions 192.7Profit for the period 60.9Taxation 86.8Net financing costs 95.0Depreciation and amortization Exceptional items: (a)0.6Information Technology Transformation program (b)68.4Business Transformation Program (c)4.3Fortenova Group integration costs (d)(0.8)Settlement of legacy matters Other Adjustments: (e)27.1Other add-backs 535.0Adjusted EBITDA (f) a. Expenses associated with the Information Technology Transformation program, which are primarily professional fees. The program was completed in 2023. b. Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees. c. Expenses associated with the integration of the Fortenova Group acquired on September 30, 2021. d. Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. e. Represents the elimination of share based payment charge including employer payroll taxes of €26.1 million and elimination of non-operating M&A related costs of €1.0 million. f. Adjusted EBITDA margin of 17.6% for the twelve months ended December 31, 2023 is calculated by dividing Adjusted EBITDA by Revenue of €3,044.5 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2023 38

------

![](b2s2025finalforposting039.jpg)

As adjusted for the twelve months ended December 31, 2022 Adjustments As reported for the twelve months ended December 31, 2022 € in millions, except per share data 2,939.7—2,939.7Revenue (2,124.4)—(2,124.4)Cost of sales 815.3—815.3Gross profit (379.5)(a)11.7(391.2)Other operating expenses —(b)48.7(48.7)Exceptional items 435.860.4375.4Operating profit 0.6(11.5)12.1Finance income (66.5)—(66.5)Finance costs (65.9)(c)(11.5)(54.4)Net financing costs 369.948.9321.0Profit before tax (76.5)(d)(5.3)(71.2)Taxation 293.443.6249.8Profit for the period 174.3174.3Weighted average shares outstanding in millions - basic 1.681.43Basic earnings per share 174.3174.3Weighted average shares outstanding in millions - diluted 1.681.43Diluted earnings per share a. Share based payment charge including employer payroll taxes of €8.6 million and non-operating M&A related costs of €3.1 million. b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (audited) twelve months ended December 31, 2022' for a detailed list of exceptional items. c. Elimination of €2.3 million of net gain recognized as part of refinancing activities and €9.2 million of foreign exchange translation gains. d. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months Ended December 31, 2022 39

------

![](b2s2025finalforposting040.jpg)

As reported for the twelve months ended December 31, 2022 € in millions 249.8Profit for the period 71.2Taxation 54.4Net financing costs 88.6Depreciation and amortization Exceptional items: (a)8.2Findus Switzerland integration costs (b)5.8Impairment of customer relationships (c)4.4Information Technology Transformation program (d)37.0Business Transformation Program (e)2.2Distribution network integration (f)9.5Fortenova Group integration costs (g)3.5Factory optimization (h)(28.9)Settlement of legacy matters (i)7.0Release of indemnification assets Other Adjustments: (j)11.7Other add-backs 524.4Adjusted EBITDA (k) a. Expenses associated with the integration of the Findus Switzerland business acquired on December 31, 2020. b. Charge for the impairment of our food service customer relationships in Sweden. c. Expenses associated with the Information Technology Transformation program, which are primarily professional fees. d. Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees. e. Expenses associated with the restructuring of the sales operations in northern Italy which was completed in 2023. f. Expenses associated with the integration of the Fortenova Group acquired on September 30, 2021. g. Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. Due to delays in delivering the program, it was extended for an additional year and completed in 2022. h. Income and expenses associated with the settlement of contingent tax receivables, tax liabilities and other liabilities relating to periods prior to acquisition by the Company. i. Charge for the release of shares held in escrow as part of the consideration on the acquisition of the Findus Group. j. Represents the elimination of share based payment charge including employer payroll taxes of €8.6 million and elimination of non-operating M&A related costs of €3.1 million. k. Adjusted EBITDA margin of 17.8% for the twelve months ended December 31, 2022 is calculated by dividing Adjusted EBITDA by Revenue of €2,939.7 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2022 40

------

![](b2s2025finalforposting041.jpg)

As adjusted for the twelve months ended December 31, 2021 Adjustments As reported for the twelve months ended December 31, 2021 € in millions, except per share data 2,606.6—2,606.6Revenue (1,853.9)(a)8.4(1,862.3)Cost of sales 752.78.4744.3Gross profit (337.6)(b)18.7(356.3)Other operating expenses —(c)45.3(45.3)Exceptional items 415.172.4342.7Operating profit 0.1—0.1Finance income (64.2)41.9(106.1)Finance costs (64.1)(d)41.9(106.0)Net financing costs 351.0114.3236.7Profit before tax (74.4)(e)(18.7)(55.7)Taxation 276.695.6181.0Profit for the period 178.1178.1Weighted average shares outstanding in millions - basic 1.551.02Basic earnings per share 178.1178.1Weighted average shares outstanding inmillions - diluted 1.551.02Diluted earnings per share a. Represents non-cash fair value uplift of inventory recorded as part of the Findus Switzerland and Fortenova acquisition purchase price accounting. b. Share based payment charge including employer payroll taxes of €5.8 million and non-operating M&A related costs of €12.9 million. c. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (audited) twelve months ended December 31, 2021' for a detailed list of exceptional items. d. Elimination of €17.9 million of charges recognized as part of refinancing activities, a one-time net €8.6 million loss from the impairment of a short-term investment, which was made with surplus cash as part of our cash management activities, €4.0 million of foreign exchange translation losses and €11.4 million of foreign exchange losses on derivatives. e. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months Ended December 31, 2021 41

------

![](b2s2025finalforposting042.jpg)

As reported for the twelve months ended December 31, 2021 € in millions 181.0Profit for the period 55.7Taxation 106.0Net financing costs 71.6Depreciation and amortization (a)8.4Acquisition purchase price adjustments Exceptional items: (b)6.2Findus Switzerland integration costs (c)5.3Brexit (d)4.2Information Technology Transformation program (e)18.8Business Transformation Program (f)3.5Fortenova Group integration costs (g)4.9Factory optimization (h)(2.6)Settlement of legacy matters (i)5.0Release of indemnification assets Other Adjustments: (j)18.7Other add-backs 486.7Adjusted EBITDA (k) a. Represents non-cash fair value uplift of inventory recorded as part of the Findus Switzerland and Fortenova acquisition purchase price accounting. b. Expenses associated with the integration of the Findus Switzerland business acquired on December 31, 2020. c. Expenses related to preparations for the potential adverse impacts of the United Kingdom exiting the European Union to our supply chain, such as tariffs and delays at ports of entry and departure. d. Expenses associated with the Information Technology Transformation program, which are primarily professional fees. e. Expenses associated with the start of a multi-year, enterprise-wide transformation and optimization program. Expenses in the period consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees. f. Expenses associated with the integration of the Fortenova Group acquired on September 30, 2021. g. Expenses associated with a three-year factory optimization program to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The project was initiated in 2018. h. Income and expenses associated with tax and other liabilities relating to periods prior to acquisition by the Company. i. Charge for the release of shares held in escrow as part of the consideration on the acquisition of the Findus Group. j. Represents the elimination of share based payment charge including employer payroll taxes of €5.8 million and elimination of non-operating M&A related costs of €12.9 million. k. Adjusted EBITDA margin of 18.7 for the twelve months ended December 31, 2021 is calculated by dividing Adjusted EBITDA by Revenue of €2,606.6 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2021 42

------

![](b2s2025finalforposting043.jpg)

As adjusted for the twelve months ended December 31, 2020 Adjustments As reported for the twelve months ended December 31, 2020 € in millions, except per share data 2,515.9—2,515.9Revenue (1,753.4)—(1,753.4)Cost of sales 762.5—762.5Gross profit (363.3)(a)19.4(382.7)Other operating expenses —(b)20.6(20.6)Exceptional items 399.240.0359.2Operating profit 0.7(4.0)4.7Finance income (66.9)1.5(68.4)Finance costs (66.2)(c)(2.5)(63.7)Net financing costs 333.037.5295.5Profit before tax (70.4)(d)—(70.4)Taxation 262.637.5225.1Profit for the period Profit attributable to: 262.737.5225.2Equity owners of the parent (0.1)—(0.1)Non-controlling interests 262.637.5225.1 194.0194.0Weighted average shares outstanding in millions - basic 1.351.16Basic earnings per share 194.0(e)(3.9)197.9Weighted average shares outstanding in millions - diluted 1.351.14Diluted earnings per share a. Share based payment charge including employer payroll taxes of €12.1 million and non-operating M&A related costs of €7.3 million. b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended December 31, 2020' for a detailed list of exceptional items. c. Elimination of €4.0 million of foreign exchange translation gains and €1.5 million of foreign exchange losses on derivatives. d. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. e. Adjustment to eliminate the dilutive effect of the Founder Preferred Share Dividend earned as of December 31, 2020 but for which shares were issued on January 4, 2021. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months ended December 31, 2020 43

------

![](b2s2025finalforposting044.jpg)

As reported for the twelve months ended December 31, 2020 € in millions 225.1Profit for the period 70.4Taxation 63.7Net financing costs 67.6Depreciation and amortization Exceptional items: (a)1.6Brexit (b)(12.5)Supply chain reconfiguration (c)0.3Findus Switzerland integration costs (d)4.0Goodfella's Pizza & Aunt Bessie's integration costs (e)10.0Factory optimization (f)17.8Release of indemnification assets (g)(2.9)Settlement of legacy matters (h)2.3Business Transformation Program Other Adjustments: (i)19.4Other add-backs 466.8Adjusted EBITDA (j) a. Expenses related to preparations for the potential adverse impacts of the United Kingdom exiting the European Union to our supply chain, such as tariffs and delays at ports of entry and departure. b. Income recognized on reaching an agreement to end the leasehold on a cold store in Sweden. c. Expenses associated with the integration of the Findus Switzerland business acquired on December 31, 2020. d. Expenses associated with the integration of the Goodfella's pizza and Aunt Bessie's businesses which were acquired in 2018. e. Expenses associated with a three-year factory optimization program to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The project was initiated in 2018. f. Charge for the release of shares held in escrow as part of the consideration on the acquisition of the Findus Group.. g. Income and expense associated with tax and other liabilities relating to periods prior to acquisition of the Findus and Iglo Groups. h. Expenses associated with the start of a multi-year, enterprise-wide transformation and optimization program. i. Represents the elimination of share based payment charge including employer payroll taxes of €12.1 million and elimination of non-operating M&A related costs of €7.3 million. j. Adjusted EBITDA margin of 18.6% for the twelve months ended December 31, 2020 is calculated by dividing Adjusted EBITDA by Revenue of €2,515.9 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2020 44

------

![](b2s2025finalforposting045.jpg)

As adjusted for the twelve months ended December 31, 2019Adjustments As reported for the twelve months ended December 31, 2019€ in millions, except per share data 2,324.3—2,324.3Revenue (1,626.4)—(1,626.4)Cost of sales 697.9—697.9Gross profit (334.2)(a)25.7(359.9)Other operating expenses —(b)54.5(54.5)Exceptional items 363.780.2283.5Operating profit 2.5—2.5Finance income (66.9)8.8(75.7)Finance costs (64.4)(c)8.8(73.2)Net financing costs 299.389.0210.3Profit before tax (64.2)(d)(7.5)(56.7)Taxation 235.181.5153.6Profit for the period Profit attributable to: 235.581.5154.0Equity owners of the parent (0.4)—(0.4)Non-controlling interests 235.181.5153.6 192.0192.0 Weighted average shares outstanding in millions - basic 1.230.80Basic earnings per share 192.0(e)(6.4)198.4 Weighted average shares outstanding in millions - diluted 1.230.78Diluted earnings per share a. Share based payment expense including employer payroll taxes of €22.4 million and non-operating M&A related costs of €3.3 million. b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended December 31, 2019' for a detailed list of exceptional items. c. Elimination of €3.9 million of foreign exchange translation losses and €4.9 million of foreign exchange losses on derivatives. d. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. e. Adjustment to eliminate the dilutive effect of the Founder Preferred Share Dividend earned as of December 31, 2019 but for which shares were issued on January 2, 2020. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months ended December 31, 2019 45

------

![](b2s2025finalforposting046.jpg)

As reported for the twelve months ended December 31, 2019 € in millions 153.6Profit for the period 56.7Taxation 73.2Net financing costs 68.3Depreciation and amortization Exceptional items: (a)1.6Brexit (b)(3.6)Supply chain reconfiguration (c)3.5Findus Group integration costs (c)12.5 Goodfella's Pizza & Aunt Bessie's integration costs (d)5.7Factory optimization (e)44.0Release of indemnification assets (f)(9.2)Settlement of legacy matters Other Adjustments: (h)25.7Other add-backs 432.0Adjusted EBITDA (i) a. Expenses related to preparations for the potential adverse impacts of the United Kingdom exiting the European Union to our supply chain, such as tariffs and delays at ports of entry and departure. b. Supply chain reconfiguration relates to activities associated with the closure of the Bjuv manufacturing facility in Sweden which ceased production in 2017. The income relates to the sale of the agricultural land which completed in May 2019 and the finalization of consideration received for the sale of the industrial property which completed in 2018. c. Expenses related to the roll-out of the Nomad ERP system following the acquisition of the Findus Group in November 2015. d. Expenses associated with the integration of the Goodfella's pizza and Aunt Bessie's businesses which were acquired in 2018. e. Expenses associated with a three-year factory optimization program to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The project was initiated in 2018. f. Charge in 2019 for the release of shares held in escrow as part of the consideration on the acquisition of the Findus Group. g. Income and expense associated with tax and other liabilities relating to periods prior to acquisition of the Findus and Iglo Groups. h. Represents the elimination of share based payment charge including employer payroll taxes of €22.4 million and elimination of non-operating M&A related costs of €3.3 million. i. Adjusted EBITDA margin of 18.6% for the twelve months ended December 31, 2019 is calculated by dividing Adjusted EBITDA by Revenue of €2,324.3 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2019 46

------

![](b2s2025finalforposting047.jpg)

As adjusted for the twelve months ended December 31, 2018Adjustments As reported for the twelve months ended December 31, 2018 € in millions, except per share data 2,172.8—2,172.8Revenue (1,513.6)(a)5.7(1,519.3)Cost of sales 659.25.7653.5Gross profit (329.1)(b)23.6(352.7)Other operating expenses —(c)17.7(17.7)Exceptional items 330.147.0283.1Operating profit 0.2(1.4)1.6Finance income (60.0)(2.4)(57.6)Finance costs (59.8)(d)(3.8)(56.0)Net financing costs 270.343.2227.1Profit before tax (61.3)(e)(4.7)(56.6)Taxation 209.038.5170.5Profit for the period 209.738.5171.2Profit for the period attributable to equity owners of the parent 175.6—175.6Weighted average shares outstanding in millions - basic 1.190.97Basic earnings per share 175.6(f)(0.2)175.8Weighted average shares outstanding in millions - diluted 1.190.97Diluted earnings per share a. Non-cash fair value uplift of inventory recorded as part of the Goodfella's Pizza and Aunt Bessie's purchase price accounting. b. Share-based payment expense including employer payroll taxes of €14.7 million and non-operating M&A transaction costs of €8.9 million. c. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended December 31, 2018' for a detailed list of exceptional items. d. Elimination of €1.1 million of costs incurred as part of the refinancing on the May 3, 2017 and repricing on December 20, 2017, €0.3 million of realized and unrealized foreign exchange translation losses and €5.2 million of gains on foreign currency derivatives. e. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. f. Adjustment to eliminate the dilutive effect of the Founder Preferred Share Dividend earned as of December 31, 2018 but for which shares were issued on January 2, 2019. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months ended December 31, 2018 47

------

![](b2s2025finalforposting048.jpg)

As reported for the twelve months ended December 31, 2018 € in millions 170.5Profit for the period 56.6Taxation 56.0Net financing costs 39.3Depreciation 7.0Amortization (a)5.7Acquisition purchase price adjustments Exceptional items: (b)1.2Supply chain reconfiguration (c)10.4Findus Group integration costs (d)8.3Goodfella's Pizza & Aunt Bessie's integration costs (e)1.6Factory optimization (f)(3.8)Settlement of legacy matters Other Adjustments: (g)23.6Other add-backs 376.4Adjusted EBITDA (h) a. Non-cash fair value uplift of inventory recorded as part of the Goodfella's Pizza and Aunt Bessie's purchase price accounting. b. Supply chain reconfiguration costs following the closure of the factory in Bjuv, Sweden. Following the closure in 2017, the Company has incurred costs relating to the relocation of production to other factories. The costs are partially offset by income from the disposal of the remaining tangible assets. c. Non-recurring costs related to the roll-out of the Nomad ERP system following the acquisition of the Findus Group in November 2015. d. Non-recurring costs associated with the integration of the Goodfella's pizza business in April 2018 and the Aunt Bessie's business in July 2018. e. Non-recurring costs associated with a three-year factory optimization program to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. f. Non-recurring income and costs associated with liabilities relating to periods prior to acquisition of the Findus and Iglo Groups, settlements of tax audits, settlements of contingent consideration for acquisitions and other liabilities relating to periods prior to acquisition of the Findus and Iglo businesses by the Company. This includes an income of €2.7 million recognized on settlement of contingent consideration for the purchase of the La Cocinera acquisition and net income of €0.7 million associated with settlements of tax audits. g. Represents the elimination of share-based payment charges including employer payroll taxes of €14.7 million and elimination of non-operating M&A related costs of €8.9 million. h. Adjusted EBITDA margin of 17.3% for the twelve months ended December 31, 2018 is calculated by dividing Adjusted EBITDA by Adjusted revenue of €2,172.8 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2018 48

------

![](b2s2025finalforposting049.jpg)

As adjusted for the twelve months ended December 31, 2017Adjustments As reported for the twelve months ended December 31, 2017 € in millions, except per share data 1,956.6—1,956.6Revenue (1,357.2)—(1,357.2)Cost of sales 599.4—599.4Gross profit (313.7)(a)5.6(319.3)Other operating expenses —(b)37.2(37.2)Exceptional items 285.742.8242.9Operating profit 0.2(7.0)7.2Finance income (59.6)22.0(81.6)Finance costs (59.4)(c)15.0(74.4)Net financing costs 226.357.8168.5Profit before tax (51.1)(d)(19.1)(32.0)Taxation 175.238.7136.5Profit for the period 176.1176.1Weighted average shares outstanding in millions - basic 1.000.78Basic earnings per share 176.1(e)(8.7)184.8Weighted average shares outstanding in millions - diluted 1.000.74Diluted earnings per sharea. Share-based payment charge b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (audited) twelve months ended December 31, 2017' for a detailed list of exceptional items. c. Elimination of €20.1 million of costs incurred as part of the refinancing on the May 3, 2017 and repricing on December 20, 2017, €3.9 million of foreign exchange translation losses and €9.0 million of foreign currency gains on derivatives. d. Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. e. Adjustment to eliminate the dilutive effect of the Founder Preferred Share Dividend earned as of December 31, 2017 but for which shares were issued on January 2, 2018. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months ended December 31, 2017 49

------

![](b2s2025finalforposting050.jpg)

As reported for the twelve months ended December 31, 2017 € in millions 136.5Profit for the period 32.0Taxation 74.4Net financing costs 35.9Depreciation 6.5Amortization Exceptional items: (a)3.2Transactions related costs (b)18.8Investigation and implementation of strategic opportunities (c)14.0Supply chain reconfiguration (d)15.1Findus Group integration costs (e)(5.6)Settlement of legacy matters (f)(8.3)Remeasurement of indemnification assets Other Adjustments: (g)5.6Other add-backs 328.1Adjusted EBITDA (h) a. Costs incurred related to enhanced control compliance procedures in territories. b. Costs incurred in relation to investigation and implementation of strategic opportunities considered non-recurring for the combined group following acquisitions by the Company. These costs primarily relate to changes to the organizational structure of the combined businesses. c. Supply chain reconfiguration costs, namely the closure of the Bjuv factory. d. Costs recognized by Nomad Foods relating to the integration of the Findus Group, primarily relating to the rollout of the Nomad ERP system. e. Non-recurring income and costs associated with liabilities relating to periods prior to acquisition of the Findus and Iglo Groups, settlements of tax audits, sale of non-operating factories acquired and other liabilities relating to periods prior to acquisition of the Findus and Iglo businesses by the Company. This includes a charge of €3.9 million associated with settlements of tax audits, offset by gains of €4.2 million from the reassessment of sales tax provisions, €1.2 million from the reassessment of interest on sales tax provisions, a €2.8 million gain on a legacy pension plan in Norway and a €1.3 million gain on disposal of a non- operational factory. f. Adjustment to reflect the remeasurement of the indemnification assets recognized on the acquisition of the Findus Group, which is capped at the value of shares held in escrow at the share price as at December 31, 2017. Offsetting are the release of indemnification assets associated with final settlement of indemnity claims against an affiliate of Permira Advisors LLP, which are legacy tax matters that predate the Company's acquisition of Iglo Group in 2015. g. Represents the elimination of share-based payment charges of €2.6 million and elimination of non-operating M&A related costs of €3.0 million. h. Adjusted EBITDA margin 16.8% for the twelve months ended December 31, 2017 is calculated by dividing Adjusted EBITDA by Adjusted revenue of €1,956.6 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2017 50

------

![](b2s2025finalforposting051.jpg)

As adjusted for the twelve months ended December 31, 2016Adjustments As reported for the twelve months ended December 31, 2016€ in millions, except per share data 1,927.7—1,927.7Revenue (1,356.7)—(1,356.7)Cost of sales 571.0—571.0Gross profit (297.2)(a)1.2(298.4)Other operating expenses —(b)134.5(134.5)Exceptional items 273.8135.7138.1Operating profit 5.9(18.3)24.2Finance income (79.2)7.1(86.3)Finance costs (73.3)(c)(11.2)(62.1)Net financing costs 200.5124.576.0Profit before tax (45.6)(d)(6.0)(39.6)Taxation 154.9118.536.4Profit for the period 183.5183.5Weighted average shares outstanding in millions - basic 0.840.20Basic earnings per share 183.5183.5Weighted average shares outstanding in millions - diluted 0.840.20Diluted earnings per share a. Adjustment to add back share based payment charge b. Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (audited) twelve months ended December 31, 2016' for a detailed list of exceptional items. c. Adjustment to eliminate €18.3 million of non-cash foreign exchange translation gains, €4.3 million foreign exchange loss on derivatives and €2.8 million of other exceptional non-cash interest. d. Adjustment to reflect the tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Twelve months ended December 31, 2016 51

------

![](b2s2025finalforposting052.jpg)

As reported for the twelve months ended December 31, 2016 € in millions 36.4Profit for the period 39.6Taxation 62.1Net financing costs 43.3Depreciation 7.8Amortization Exceptional items: (a)4.8Costs related to transactions (b)1.9Costs related to management incentive plans (c)7.0Investigation and implementation of strategic opportunities (d)(4.3)Cisterna fire net income (e)84.3Supply chain reconfiguration (f)(1.0)Other restructuring costs (g)29.6Findus Group integration costs (h)1.8Settlement of legacy matters (i)10.4Remeasurement of indemnification assets Other Adjustments: (j)1.2Other add-backs 324.9Adjusted EBITDA (k) a. Elimination of costs incurred in relation to completed and potential acquisitions and one-off compliance costs incurred as a result of listing on the New York Stock Exchange. b. Adjustment to eliminate long term management incentive scheme costs from prior ownership. c. Elimination of costs incurred in relation to investigation and implementation of strategic opportunities considered non-recurring for the combined group following acquisitions by the Company. These costs primarily relate to changes to the organizational structure of the combined businesses. d. Elimination of net insurance income offset by incremental operational costs incurred as a result of a fire in August 2014 in the Iglo Group's Italian production facility which produces Findus branded stock for sale in Italy. e. Elimination of supply chain reconfiguration costs, namely the closure of the Bjuv factory. f. Elimination of a credit on release of provisions for restructuring activities associated with operating locations. g. Elimination of costs recognized by Nomad Foods relating to the integration of the Findus Group. h. Elimination of non-recurring costs associated with settlements of tax audits and other liabilities relating to periods prior to acquisition of the Findus and Iglo businesses by the Company. These were previously classified within Investigation and implementation of strategic opportunities and other items and have been reclassified into this line for the period presented. i. Adjustment to reflect the remeasurement of the indemnification assets recognized on the acquisition of the Findus Group, which is capped at the value of shares held in escrow at the share price as at December 31, 2016. j. Other add-backs include the elimination of share-based payment charges of €1.2 million. k. Adjusted EBITDA margin 16.9% for the twelve months ended December 31, 2016 is calculated by dividing Adjusted EBITDA by Adjusted revenue of €1,927.7 million. 2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted EBITDA (audited) Twelve months ended December 31, 2016 52

------

![](b2s2025finalforposting053.jpg)

53 2. Reconciliation of Non-IFRS Financial Measures Three months ended June 30, 2025 Three months ended March 31, 2025 Three months ended December 31, 2024 Three Months Ended September 30, 2024 Three Months Ended June 30, 2024 Three Months Ended March 31, 2024 YoY ChangeYoY ChangeYoY ChangeYoY ChangeYoY ChangeYoY Change (0.8)%(3.0)%4.3%0.8%1.1%1.1%Reported Revenue Growth Of which: (1.1)%(3.6)%3.1%0.3%0.5%0.3%- Organic Revenue Growth 0.3%0.6%1.2%0.5%0.6%0.8%- Translational FX (a) (0.8)%(3.0)%4.3%0.8%1.1%1.1%Total Year on Year Growth – quarter vs the same quarter of previous year Reconciliation from reported to organic revenue growth/(decline) The following table is a reconciliation of reported revenue growth to Organic Revenue Growth for the three month periods ended March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, and June 30, 2025, compared to the same quarter of the previous year. a. Translational FX is calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.

------

![](b2s2025finalforposting054.jpg)

54 Reconciliation of reported net cash flows from operating activities to Free cash flow and Adjusted free cash flow for the years ended December 31, 2024, 2023, 2022, 2021, 2020, 2019, 2018 & 2017. 8 year total20172018201920202021202220232024€ in millions, Year ended 193.8321.3315.4457.0306.3303.8430.8435.4Net cash flows from operating activities Deduct: (42.6)(41.6)(47.3)(58.7)(79.2)(79.1)(82.4)(80.3)Capital expenditure (a) (48.5)(45.1)(46.0)(49.5)(36.6)(53.6)(88.6)(102.0)Net interest paid 1.6(2.8)0.7(6.1)(2.0)0.3(0.4)—Other financing cash flows (b) (1.6)—(21.8)(20.3)(19.4)(26.5)(30.1)(31.3)Payment of lease liabilities (c) 102.7231.8201.0322.4169.1144.9229.3221.8Free cash flow Add back: 99.543.415.912.148.840.867.667.7Cash flows relating to exceptional items (d) 27.3———————Legacy tax payments (e) —1.77.53.10.70.52.01.6Employer taxes related to share based payments (f) 3.08.93.37.312.93.11.01.2Non-operating M&A costs (g) 2,103.9232.5285.8227.7344.9231.5189.3299.9292.3Adjusted free cash flow 2,015.5175.2209.0235.1262.6276.6293.4274.8288.8Adjusted profit for the period 104%133%137%97%131%84%65%109%101%Adjusted free cash flow as % adjusted profit for the period 20,660.21,956.62,172.82,324.32,515.92,606.62,939.73,044.53,099.8Revenue 10%12%13%10%14%9%6%10%9%Adjusted free cash flow as % revenue a. Defined as the sum of property, plant and equipment and intangible assets purchased in the year, which are considered part of the underlying business cash flows. b. Proceeds/(payments) on settlement of derivatives. c. These lease liabilities are included in Net Cash Flows from Financing Activities. We believe these payments are part of the underlying business cash flows and should be reflected in Adjusted free cash flow. d. Adjustment to add back cash flows related to exceptional items which are not considered to be indicative of our ongoing operating cash flows. e. Tax paid relating to open tax audits for pre-Nomad periods which are considered one-off in nature. f. Adjustment to add back working capital movements related to employer taxes on share based payments which are not considered to be indicative of our ongoing operating cash flows. g. Adjustment to add back cash flows related to non-operating M&A costs which are not considered to be indicative of our ongoing operating cash flows. 2. Reconciliation of Non-IFRS Financial Measures (continued)

------